2025-04-14 22:05:23
Latest Post
Sasken Technologies completes acquisition of Borqs Technologies to Strengthen IoT and 5G Product Engineering Capabilities
Tata Power Renewable Energy Ltd reaches 10.9 GW capacity after signing PPA with NTPC Ltd for 200 MW Firm and Dispatchable Renewable Energy Project
Cyient secures Strategic Engagement with GreenH and Luxcara for Hydrogen Project in Bodø, Norway
Interarch wins Double Honours at CIDC Vishwakarma Awards 2025
Godrej Industries' Chemicals Business acquires Business of Savannah Surfactants Limited
Stock Report
Morepen Laboratories Ltd consolidated Q4FY23 profit at Rs. 8.24 crores
Posted On : 2023-05-16 16:58:19( TIMEZONE : IST )
Morepen Laboratories Limited has reported Consolidated financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 366.8080 crores during the period ended March 31, 2023 as compared to Rs. 349.6881 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. 8.2415 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 8.9932 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. 0.16 for the period ended March 31, 2023 as compared to Rs. 0.16 for the period ended December 31, 2022.
| Financials | Q4 FY2023 | Q3 FY2023 | % Change |
| Total Income | ₹366.8080 crs | ₹349.6881 crs |  4.90% |
| Net Profit | ₹8.2415 crs | ₹8.9932 crs |  -8.36% |
| EPS | ₹0.16 | ₹0.16 |  0.00% |
Financial Results (Q4 FY2023) - YoY Comparison
The company has reported total income of Rs.366.8080 crores during the period ended March 31, 2023 as compared to Rs.371.4634 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.8.2415 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.12.3224 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.0.16 for the period ended March 31, 2023 as compared to Rs.0.24 for the period ended March 31, 2022.
| Financials | Q4 FY2023 | Q4 FY2022 | % Change |
| Total Income | ₹366.8080 crs | ₹371.4634 crs | -1.25% |
| Net Profit | ₹8.2415 crs | ₹12.3224 crs | -33.12% |
| EPS | ₹0.16 | ₹0.24 | -33.33% |
Financial Results (Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.1423.6634 crores during the Financial Year ended March 31, 2023 as compared to Rs.1557.1341 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.38.6755 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.101.6813 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.0.77 for the Financial Year ended March 31, 2023 as compared to Rs.1.96 for the Financial Year ended March 31, 2022.
| Financials | Year Ended FY2023 | Year Ended FY2022 | % Change |
| Total Income | ₹1423.6634 crs | ₹1557.1341 crs | -8.57% |
| Net Profit | ₹38.6755 crs | ₹101.6813 crs | -61.96% |
| EPS | ₹0.77 | ₹1.96 | -60.71% |
Shares of Morepen Laboratories Limited was last trading in BSE at Rs. 27.07 as compared to the previous close of Rs. 27.04. The total number of shares traded during the day was 282556 in over 851 trades.
The stock hit an intraday high of Rs. 27.31 and intraday low of 26.90. The net turnover during the day was Rs. 7665385.00.
